Suppr超能文献

感染:历史、流行病学、风险因素、预防、临床表现、治疗和未来选择。

infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.

机构信息

Clinical Department of Medical, Surgical and Health Sciences, Trieste University, Trieste, Italy.

Infectious Diseases Unit, Trieste University Hospital (ASUGI), Trieste, Italy.

出版信息

Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.

Abstract

SUMMARY infection (CDI) is one of the major issues in nosocomial infections. This bacterium is constantly evolving and poses complex challenges for clinicians, often encountered in real-life scenarios. In the face of CDI, we are increasingly equipped with new therapeutic strategies, such as monoclonal antibodies and live biotherapeutic products, which need to be thoroughly understood to fully harness their benefits. Moreover, interesting options are currently under study for the future, including bacteriophages, vaccines, and antibiotic inhibitors. Surveillance and prevention strategies continue to play a pivotal role in limiting the spread of the infection. In this review, we aim to provide the reader with a comprehensive overview of epidemiological aspects, predisposing factors, clinical manifestations, diagnostic tools, and current and future prophylactic and therapeutic options for infection.

摘要

总结

艰难梭菌感染(CDI)是医院获得性感染的主要问题之一。这种细菌在不断进化,给临床医生带来了复杂的挑战,在现实生活中经常遇到。面对 CDI,我们越来越多地配备了新的治疗策略,如单克隆抗体和活体生物治疗产品,需要彻底了解这些策略,以充分发挥它们的优势。此外,目前正在研究未来的有趣选择,包括噬菌体、疫苗和抗生素抑制剂。监测和预防策略继续在限制感染传播方面发挥着关键作用。在这篇综述中,我们旨在为读者提供艰难梭菌感染的流行病学方面、易患因素、临床表现、诊断工具以及当前和未来的预防和治疗选择的全面概述。

相似文献

1
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0013523. doi: 10.1128/cmr.00135-23. Epub 2024 Feb 29.
2
Prevention of Infection due to Clostridium (Clostridioides) difficile.
Infect Dis Clin North Am. 2021 Dec;35(4):995-1011. doi: 10.1016/j.idc.2021.07.009.
3
Clostridioides difficile: Current overview and future perspectives.
Adv Protein Chem Struct Biol. 2022;129:215-245. doi: 10.1016/bs.apcsb.2021.11.003. Epub 2022 Jan 7.
4
Review article: The epidemiology and management of Clostridioides difficile infection-A clinical update.
Aliment Pharmacol Ther. 2024 Jun;59(11):1335-1349. doi: 10.1111/apt.17975. Epub 2024 Mar 27.
6
Problems of infection (CDI) in Polish healthcare units.
Ann Agric Environ Med. 2021 Jun 14;28(2):224-230. doi: 10.26444/aaem/119321. Epub 2020 Apr 2.
7
Prevention of Clostridioides difficile in hospitals: A position paper of the International Society for Infectious Diseases.
Int J Infect Dis. 2021 Jan;102:188-195. doi: 10.1016/j.ijid.2020.10.039. Epub 2020 Oct 27.
9
Strategies to prevent adverse outcomes following infection in the elderly.
Expert Rev Anti Infect Ther. 2020 Mar;18(3):203-217. doi: 10.1080/14787210.2020.1717950. Epub 2020 Jan 27.
10
Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
J Pediatric Infect Dis Soc. 2021 Nov 17;10(Supplement_3):S64-S68. doi: 10.1093/jpids/piab052.

引用本文的文献

1
Impact of Acid Suppressants on the Development of Infection and Possible Preventive Effects of Probiotic Formulations.
Infect Drug Resist. 2025 Aug 31;18:4593-4602. doi: 10.2147/IDR.S543864. eCollection 2025.
2
Dominance of toxigenic strains and the appearance of the emerging PCR ribotype 955 in hospitals in Silesia, Poland.
Front Microbiol. 2025 Aug 11;16:1644051. doi: 10.3389/fmicb.2025.1644051. eCollection 2025.
4
Epidemiology and genetic characteristics of isolates in Northwest China.
PeerJ. 2025 Aug 15;13:e19877. doi: 10.7717/peerj.19877. eCollection 2025.
5
The role of Frailty Index Laboratory in predicting clinical outcomes in patients with infections: a 2020-24 single-centre retrospective study.
JAC Antimicrob Resist. 2025 Aug 8;7(4):dlaf143. doi: 10.1093/jacamr/dlaf143. eCollection 2025 Aug.
9
Effect of Pefloxacin on R20291 Persister Cells Formation.
Antibiotics (Basel). 2025 Jun 20;14(7):628. doi: 10.3390/antibiotics14070628.
10
-Cresol and : A Love-Hate Story Revealed by Raman Spectroscopy.
Anal Chem. 2025 Aug 5;97(30):16583-16592. doi: 10.1021/acs.analchem.5c02927. Epub 2025 Jul 23.

本文引用的文献

1
Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.
Nat Med. 2023 Oct;29(10):2526-2534. doi: 10.1038/s41591-023-02549-4. Epub 2023 Sep 18.
5
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
J Am Geriatr Soc. 2023 Nov;71(11):3530-3537. doi: 10.1111/jgs.18500. Epub 2023 Jul 17.
6
Proton pump inhibitor use: systematic review of global trends and practices.
Eur J Clin Pharmacol. 2023 Sep;79(9):1159-1172. doi: 10.1007/s00228-023-03534-z. Epub 2023 Jul 7.
9
Unusual Case of Pseudomembranous Colitis Presenting as Fever of Unknown Origin Diagnosed by Tc-99m-HMPAO-labeled Leukocytes SPECT/CT.
Mol Imaging Radionucl Ther. 2023 Jun 20;32(2):168-170. doi: 10.4274/mirt.galenos.2022.59354.
10
Clostridium difficile in inflammatory bowel disease.
Curr Opin Gastroenterol. 2023 Jul 1;39(4):257-262. doi: 10.1097/MOG.0000000000000949. Epub 2023 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验